Professional Publications

Mambet, C.; Babosova, O.; Defour, J.-P.; Leroy, E.; Necula, L.; Stanca, O.; Tatic, A.; Berbec, N.; Coriu, D.; Belickova, M.; et al.

Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms

[year of publication 2019, impact factor 16.601 ]

Barnes, D.M.; Hanby, A.M.; Gillett, C.E.; Mohammed, S.; Hodgson, S.; Bobrow, L.G.; Leigh, I.M.; Purkis, T.; MacGeoch, C.; Spurr, N.K.; Bartek, J.; Vojtesek, B.; Picksley, S.M.; Lane, D.P.

Abnormal expression of wild type p53 protein in normal cells of a cancer family patients

[year of publication 2006, impact factor 15.940]

Prchal, J.T.; Prchal, J.F.; Belickova, M.; Chen, S.; Guan, Y.; Gartland, G.L.; Cooper, M.D.

Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism

[year of publication 2006, impact factor 15.572]

Hovorkova, L.; Zaliova, M.; Venn, N.C.; Bleckmann, K.; Trkova, M.; Potuckova, E.; Vaskova, M.; Linhartova, J.; Machova Polakova, K.; Fronkova, E.; Muskovic, W.; Giles, J.E.; Shaw, P.J.; Cario, G.; Sutton, R.; Stary, J.; Trka, J.; Zuna, J.

Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology

[year of publication 2017, impact factor 15.132 ]

Klug, S.J.; Ressing, M.; Koenig, J.; Abba, M.C.; Agorastos, T.; Brenna, S.M.; Ciotti, M.; Das, B.R.; Del Mistro, A.; Dybikowska, A.; Giuliano, A.R.; Gudleviciene, Z.; Gyllensten, U.; Haws, A.L.; Helland, A.; Herrington, C.S.; Hildesheim, A.; Humbey, O.; Jee, S.H.; Kim, J.W.; Madeleine, M.M.; Menczer, J.; Ngan, H.Y.; Nishikawa, A.; Niwa, Y.; Pegoraro, R.; Pillai, M.R.; Ranzani, G.; Rezza, G.; Rosenthal, A.N.; Roychoudhury, S.; Saranath, D.; Schmitt, V.M.; Sengupta, S.; Settheetham-Ishida, W.; Shirasawa, H.; Snijders, P.J.; Stoler, M.H.; Suárez-Rincón, A.E.; Szarka, K.; Tachezy, R.; Ueda, M.; van der Zee, A.G.; von Knebel Doeberitz, M.; Wu, M.-T.; Yamashita, T.; Zehbe, I.; Blettner, M.

TP53 codon 72 polymorphism and cervical cancer : a pooled analysis of individual data from 49 studies

[year of publication 2009, impact factor 14.470]

Buske, C.; Hutchings, M.; Ladetto, M.; Goede, V.; Mey, U.; Soubeyran, P.; Spina, M.; Stauder, R.; Trněný, M.; et al.

ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

[year of publication 2018, impact factor 14.196 ]

Steiner, P.; Philipp, A.; Lukas, J.; Godden-Kent, D.; Pagano, M.; Mittnacht, S.; Bartek, J.; Eilers, M.

Identification of a Myc-dependent step during the formation of active G(1) cyclin-cdk complexes

[year of publication 2006, impact factor 13.505]

Pfeilstöcker, M.; Tuechler, H.; Sanz, G.; Schanz, J.; Garcia-Manero, G.; Solé, F.; Bennett, J.M.; Bowen, D.; Fenaux, P.; Dreyfus, F.; Kantarjian, H.; Kuendgen, A.; Malcovati, L.; Cazzola, M.; Cermak, J.; Fonatsch, C.; Le Beau, M.M.; Slovak, M.L.; Levis, A.; Luebbert, M.; Maciejewski, J.; Machherndl-Spandl, S.; Magalhaes, S.M.; Miyazaki, Y.; Sekeres, M.A.; Sperr, W.R.; Stauder, R.; Tauro, S.; Valent, P.; Vallespi, T.; van de Loosdrecht, A.A.; Germing, U.; Haase, D.; Greenberg, P.L.

Time-dependent changes in mortality and transformation risk in MDS

[year of publication 2016, impact factor 13.164 ]

Greenberg, P.L.; Tuechler, H.; Schanz, J.; Sanz, G.; Garcia-Manero, G.; Solé, F.; Bennett, J.M.; Bowen, D.; Fenaux, P.; Dreyfus, F.; Kantarjian, H.; Kuendgen, A.; Levis, A.; Malcovati, L.; Cazzola, M.; Cermak, J.; Fonatsch, C.; Le Beau, M.M.; Slovak, M.L.; Krieger, O.; Luebbert, M.; Maciejewski, J.; Magalhaes, S.M.; Miyazaki, Y.; Pfeilstöcker, M.; Sekeres, M.; Sperr, W.R.; Stauder, R.; Tauro, S.; Valent, P.; Vallespi, T.; van de Loosdrecht, A.A.; Germing, U.; Haase, D.

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

[year of publication 2016, impact factor 13.164 ]

Fucikova, J.; Truxova, I.; Hensler, M.; Becht, E.; Kasikova, L.; Moserova, I.; Vosahlikova, S.; Klouckova, J.; Church, S.E.; Cremer, I.; Kepp, O.; Kroemer, G.; Galluzzi, L.; Salek, C.; Spisek, R.

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

[year of publication 2017, impact factor 13.164 ]

Basak, A.; Hancarova, M.; Ulirsch, J.C.; Balci, T.B.; Trkova, M.; Pelisek, M.; Vlckova, M.; Muzikova, K.; Cermak, J.; Trka, J.; Dyment, D.A.; Orkin, S.H.; Daly, M.J.; Sedlacek, Z.; Sankaran, V.G.

BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations

[year of publication 2015, impact factor 12.575 ]

da Silva-Coelho, P.; Kroeze, L.I.; Yoshida, K.; Koorenhof-Scheele, T.N.; Knops, R.; van de Locht, L.T.; de Graaf, A.O.; Massop, M.; Sandmann, S.; Dugas, M.; Stevens-Kroef, M.J.; Cermak, J.; et al.

Clonal evolution in myelodysplastic syndromes

[year of publication 2017, impact factor 12.353 ]

Lukáš, J.; Bártková, J.; Müller, H.; Spitkovsky, D.; Kjerulff, A.A.; Jansen-Dürr, P.; Strauss, M.; Bártek, J.

DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cells requirement for cyclin D1 function in G1

[year of publication 2006, impact factor 12.149]

White, H.; Deprez, L.; Corbisier, P.; Hall, V.; Lin, F.; Mazoua, S.; Trapmann, S.; Aggerholm, A.; Andrikovics, H.; Akiki, S.; Barbany, G.; Boeckx, N.; Bench, A.; Catherwood, M.; Cayuela, J.-M.; Chudleigh, S.; Clench, T.; Colomer, D.; Daraio, F.; Dulucq, S.; Farrugia, J.; Fletcher, L.; Foroni, L.; Ganderton, R.; Gerrard, G.; Gineikiene, E.; Hayette, S.; El Housni, H.; Izzo, B.; Jansson, M.; Johnels, P.; Jurcek, T.; Kairisto, V.; Kizilors, A.; Kim, D.-W.; Lange, T.; Lion, T.; Polakova, K.M.; Martinelli, G.; McCarron, S.; Merle, P.A.; Milner, B.; Mitterbauer-Hohendanner, G.; Nagar, M.; Nickless, G.; Nomdedeu, J.; Nymoen, D.A.; Leibundgut, E.O.; Ozbek, U.; Pajic, T.; Pfeifer, H.; Preudhomme, C.; Raudsepp, K.; Romeo, G.; Sacha, T.; Talmaci, R.; Touloumenidou, T.; Van der Velden, V.H.J.; Waits, P.; Wang, L.; Wilkinson, E.; Wilson, G.; Wren, D.; Zadro, R.; Ziermann, J.; Zoi, K.; Muller, M.C.; Hochhaus, A.; Schimmel, H.; Cross, N.C.P.; Emons, H.

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR

[year of publication 2014, impact factor 12.104 ]

Tanase, A.; Schmitz, N.; Stein, H.; Boumendil, A.; Finel, H.; Castagna, L.; Blaise, D.; Milpied, N.; Sucak, G.; Sureda, A.; Thomson, K.; Vandenberghe, E.; Vitek, A.; Dreger, P.

Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party

[year of publication 2015, impact factor 12.104 ]

Cross, N.C.; White, H.E.; Colomer, D.; Ehrencrona, H.; Foroni, L.; Gottardi, E.; Lange, T.; Lion, T.; Machova Polakova, K.; Dulucq, S.; Martinelli, G.; Oppliger Leibundgut, E.; Pallisgaard, N.; Barbany, G.; Sacha, T.; Talmaci, R.; Izzo, B.; Saglio, G.; Pane, F.; Müller, M.C.; Hochhaus, A.

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

[year of publication 2015, impact factor 12.104 ]

Della Porta, M.G.; Tuechler, H.; Malcovati, L.; Schanz, J.; Sanz, G.; Garcia-Manero, G.; Solé, F.; Bennett, J.M.; Bowen, D.; Fenaux, P.; Dreyfus, F.; Kantarjian, H.; Kuendgen, A.; Levis, A.; Cermak, J.; Fonatsch, C.; Le Beau, M.M.; Slovak, M.L.; Krieger, O.; Luebbert, M.; Maciejewski, J.; Magalhaes, S.M.; Miyazaki, Y.; Pfeilstöcker, M.; Sekeres, M.A.; Sperr, W.R.; Stauder, R.; Tauro, S.; Valent, P.; Vallespi, T.; van de Loosdrecht, A.A.; Germing, U.; Haase, D.; Greenberg, P.L.; Cazzola, M.

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R): a study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

[year of publication 2015, impact factor 12.104 ]

Rawstron, A.C.; Fazi, C.; Agathangelidis, A.; Villamor, D.; Letestu, R.; Nomdedeu, J.; Palacio, C.; Stehlikova, O.; Kreuzer, K.-A.; Liptrot, S.; O'Brien, D.; De Tute, R.M.; Marinov, I.; Hauwel, M.; Spacek, M.; Dobber, J.; Kater, A.P.; Gambell, P.; Soosapilla, A.; Lozanski, G.; Brachtl, G.; Lin, K.; Boysen, J.; Hanson, C.; Jorgensen, J.L.; Stetler-Stevenson, M.; Yuan, C.; Broome, H.E.; Rassenti, L.; Craig, F.; Delgado, J.; Moreno, C.; Bosch, F.; Egle, A.; Doubek, M.; Pospisilova, S.; Mulligan, S.; Westerman, D.; Sanders, C.M.; Emerson, R.; Robins, H.S.; Kirsch, I.; Shanafelt, T.; Pettitt, A.; Kipps, T.J.; Wierda, W.G.; Cymbalista, F.; Hallek, M.; Hillmen, P.; Montserrat, E.; Ghia, P.

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

[year of publication 2016, impact factor 11.702 ]

Soverini, S.; De Benedittis, C.; Papayannidis, C.; Polakova, K.M.; Venturi, C.; Russo, D.; Bresciani, P.; Iurlo, A.; Mancini, M.; Vitale, A.; Chiaretti, S.; Foa, R.; Abruzzese, E.; Sora, F.; Kohlmann, A.; Haferlach, T.; Baccarani, M.; Cavo, M.; Martinelli, G.

Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients

[year of publication 2016, impact factor 11.702 ]

Cross, N.C.P.; White, H.E.; Ernst, T.; Welden, L.; Dietz, C.; Saglio, G.; Mahon, F.-X.; Wong, C.C.; Zheng, D.; Wong, S.; Wang, S.-S.; Akiki, S.; Albano, F.; Andrikovics, H.; Anwar, J.; Balatzenko, G.; Bendit, I.; Beveridge, J.; Boeckx, N.;Cerveira, N.; Cheng, S.-M.; Colomer, D.; Czurda, S.; Daraio, F.; Dulucq, S.; Eggen, L.; El Housni, H.; Gerrard, G.; Gniot, M.; Izzo, B.; Jacquin, D.; Janssen, J.J.W.M.; Jeromin, S.; Jurcek, T.; Kim, D.-W.; Machova-Polakova, K.; Martinez-Lopez, J.; McBean, M.; Mesanovic, S.; Mitterbauer-Hohendanner, G.; Mobtaker, H.; Mozziconacci, M.-J.; Pajič, T.; Pallisgaard, N.; Panagiotidis, P.; Press, R.D.; Qin, Y.-Z.; Radich, J.; Sacha, T.; Touloumenidou, T.; Waits, P.; Wilkinson, E.; Zadro, R.; Müller, M.C.; Hochhaus, A.; Branford, S.

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

[year of publication 2016, impact factor 11.702 ]